[go: up one dir, main page]

MX2010006223A - Terapias de combinacion usando acetato de melengestrol y zilpaterol o sus sales. - Google Patents

Terapias de combinacion usando acetato de melengestrol y zilpaterol o sus sales.

Info

Publication number
MX2010006223A
MX2010006223A MX2010006223A MX2010006223A MX2010006223A MX 2010006223 A MX2010006223 A MX 2010006223A MX 2010006223 A MX2010006223 A MX 2010006223A MX 2010006223 A MX2010006223 A MX 2010006223A MX 2010006223 A MX2010006223 A MX 2010006223A
Authority
MX
Mexico
Prior art keywords
combinations
zilpaterol
salts
melengestrol acetate
combination therapies
Prior art date
Application number
MX2010006223A
Other languages
English (en)
Inventor
Mary Irene Wray
Damon Edward Bradley
Melissa A Peterson
Auddie Sharp
Celia Shelton
Jayden Lloyd Montgomery
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2010006223A publication Critical patent/MX2010006223A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Insects & Arthropods (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

La presente invención generalmente se refiere a un método para promover el crecimiento e incremento de eficiencia de uso de alimentación en animales, y más específicamente a combinaciones que comprenden zilpaterol (y sales del mismo) y acetato de melengestrol. Incluidos dentro de la invención son los métodos de tratamiento que comprenden la administración de estas combinaciones a animales, composiciones que comprenden tales combinaciones, usos de estas combinaciones para preparar medicamentos y kits para usar estas combinaciones.
MX2010006223A 2007-12-06 2008-12-04 Terapias de combinacion usando acetato de melengestrol y zilpaterol o sus sales. MX2010006223A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99292207P 2007-12-06 2007-12-06
PCT/US2008/085455 WO2009073756A1 (en) 2007-12-06 2008-12-04 Combination therapies using melengestrol acetate and zilpaterol or its salts

Publications (1)

Publication Number Publication Date
MX2010006223A true MX2010006223A (es) 2010-08-10

Family

ID=40364343

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010006223A MX2010006223A (es) 2007-12-06 2008-12-04 Terapias de combinacion usando acetato de melengestrol y zilpaterol o sus sales.

Country Status (7)

Country Link
US (1) US8580772B2 (es)
CN (1) CN101918001B (es)
AU (1) AU2008333844B2 (es)
BR (1) BRPI0820591A2 (es)
CA (1) CA2708044C (es)
MX (1) MX2010006223A (es)
WO (1) WO2009073756A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201033217A (en) 2008-12-17 2010-09-16 Intervet Int Bv Process for making a crystalline zilpaterol salt
US9313927B2 (en) * 2010-11-08 2016-04-12 Chatsworth Products, Inc. Header panel assembly for preventing air circulation above electronic equipment enclosure
CN102134266B (zh) * 2010-12-30 2012-11-07 北京市科益丰生物技术发展有限公司 一种美仑孕酮醋酸酯的制备方法
BR112014028449A2 (pt) * 2012-05-18 2017-06-27 Intervet Int Bv método para intensificar o desempenho de frangos de corte.
CA2902257A1 (en) * 2013-03-15 2014-09-18 Intervet International B.V. A method of improving the efficiency of beef production from bovine animals
WO2014140236A1 (en) * 2013-03-15 2014-09-18 Intervet International B.V. Top dress feeding of zilpaterol in cattle
WO2017013623A1 (en) * 2015-07-23 2017-01-26 Biogénesis Bagó Argentina S.A. Use of intravaginal device to increase weight gain and improve carcass quality in bovine females
BR112018077032A2 (pt) * 2016-06-23 2019-04-02 Nutrivert Llc método para aprimorar o crescimento ou a conversão alimentar em um animal, uso de pgn, mdp ou um análogo de mdp na preparação de um medicamento e pgn, mdp ou um análogo de mdp
US20200015498A1 (en) * 2017-04-04 2020-01-16 Hermann Roth Animal feed with beta adrenergic agonist and isoquinoline alkaloid
WO2019056051A1 (en) * 2017-09-22 2019-03-28 4 Season Company Pty Ltd FOOD SUPPLEMENT REDUCING EMISSIONS
US12492222B2 (en) 2020-03-26 2025-12-09 Nutrivert Inc. Lipophilic enantiomers of desacetylglucosamine muramyl dipeptide with anti-inflammatory and growth promoting activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3359287A (en) 1959-11-16 1967-12-19 Upjohn Co 16-methylene-17alpha-hydroxy progesterones and derivatives thereof
US3417182A (en) 1963-03-25 1968-12-17 Upjohn Co Compositions and treatments using 6-methyl - 16 - methylene - 17alpha - hydroxy-4,6-pregnadiene-3,20-dione 17-acetate
US4154748A (en) 1978-01-20 1979-05-15 The Upjohn Company Phosphate catalyzed acylation of steroidal tertiary alcohols
FR2534257A1 (fr) 1982-10-12 1984-04-13 Roussel Uclaf Nouveaux derives de la 6-amino 7-hydroxy 4,5,6,7-tetrahydro-imidazo/4,5,1-j-k/ /1/ benzazepin-2(1h)-one, leurs sels, application a titre de medicaments, compositions les renfermant et un intermediaire
IE60964B1 (en) * 1986-12-11 1994-09-07 Roussel Uclaf Zootechnical compositions containing a beta-adrenergic
FR2735474B1 (fr) 1995-06-13 1997-08-08 Roussel Uclaf Chlorhydrate de zilpaterol sous une forme cristallisee particuliere, son procede de preparation et les produits intermediaires mis en oeuvre
US6498153B1 (en) 1998-12-31 2002-12-24 Akzo Nobel N.V. Extended release growth promoting two component composition
US7207289B2 (en) * 2004-05-20 2007-04-24 Intervet International B.V. Method of feeding the cattle with feed additives that increases beef production and reduces liver abscess
WO2008006828A1 (en) * 2006-07-10 2008-01-17 Intervet International B.V. Zilpaterol enantiomer compositions and methods of making and using such compositions

Also Published As

Publication number Publication date
BRPI0820591A2 (pt) 2015-06-16
AU2008333844B2 (en) 2014-06-26
CA2708044C (en) 2017-01-03
CN101918001B (zh) 2016-11-16
CN101918001A (zh) 2010-12-15
CA2708044A1 (en) 2009-06-11
AU2008333844A1 (en) 2009-06-11
US20090181906A1 (en) 2009-07-16
US8580772B2 (en) 2013-11-12
WO2009073756A1 (en) 2009-06-11

Similar Documents

Publication Publication Date Title
MX2010006223A (es) Terapias de combinacion usando acetato de melengestrol y zilpaterol o sus sales.
MX2009012690A (es) Composiciones, metodos, dispositivos y sistemas para el cuidado bucal.
TR200906329T1 (tr) Kanser Hastalarında Kemik Gelişimini Desteklemek için A
EA201100153A1 (ru) Никотинсодержащие мягкие желатиновые пастилки
MX2011011950A (es) Composiciones de dexmedetomidina sublinguales y metodos de uso de las mismas.
MY166789A (en) Arginine salts and their uses for the treatment of illnesses in the oral cavity
MY163477A (en) Pyrimidinyl-pyridazinone derivatives
EP2592073A3 (en) Human protein tyrosine phosphatase inhibitors and their use
WO2013029013A8 (en) Enzyme producing bacillus strains
MY147994A (en) Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors
MX2011007930A (es) Conjugados de insulina cristalina.
WO2009114703A3 (en) Combination therapy for the treatment of cancer
IN2012DN01292A (es)
GEP20115293B (en) Isolated extract of walnuts, process for its obtaining and its use
TW200730518A (en) Crystalline forms of docetaxel and processes for their preparation
MY150931A (en) Substituted oxazolidinones and their use
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
MX2009007384A (es) Formulaciones que contienen ?-lactama con elevada estabilidad en disolucion acuosa.
PH12013500371A1 (en) Therapeutic agent for pain
MX390695B (es) Composiciones farmaceuticas solidas antidiabeticas
AU2011343331A8 (en) Compositions based on clay and bee pollen, method for preparing same, and nutritional and therapeutic uses thereof
TN2010000266A1 (en) Oxazolidinones for the treatment and/or prophylaxis of heart failure
RU2009146799A (ru) Кормовая добавка для молодняка крупного рогатого скота с иммуностимулирующей активностью
ZA200705490B (en) Substituted benzimidazoles for treatment of histomoniasis
MX2008011017A (es) Compuestos de receptor sigma.

Legal Events

Date Code Title Description
FG Grant or registration